Pharmaceuticals News and Research

RSS

20 cancer survivors, loved ones and experts to join Lance Armstrong in raising cance awareness

Twenty cyclists have been selected by cancer Community leaders to join cancer survivor and five-time Tour de France champion Lance Armstrong in the Bristol-Myers Squibb Tour of Hope.

2 Jun 2004

Autodesk engineering solution addresses healthcare design challenges

Autodesk, Inc., a leading design software and digital content company, has announced that engineering firms are increasingly using Autodesk(R) Building Systems to create, manage and share critical building design information for healthcare, biomedical research and biopharmaceutical projects.

31 May 2004

There are still benefits from hormone therapy after menopause

Despite the highly publicized closing of the Women’s Health Initiative study, the scientific community should not rule out that women may benefit from hormone therapy after menopause, say researchers at UC Davis, Duke and Harvard Universities.

31 May 2004

Olympic organizers and world pharmaceutical representatives agree on working hours

Representatives of the pharmaceutical world (chemists, pharmaceutical wholesale stores and industries) and ATHENS 2004 agreed today on the working hours and pharmaceutical provisioning times at Games-time, confirming the partial agreements reached after the dialogue started in November 2003.

27 May 2004

Research tests the efficacy of a smallpox vaccine candidate known as LC16m8

When used as an aerosolized weapon, smallpox could be controlled by a new vaccine under study at Saint Louis University School of Medicine, according to new data.

27 May 2004

Bipolar disorder, one of the illnesses that will be studied and treated at the new Mood Disorders Centre of Excellence

Imagine suffering frequent, extreme and disabling mood swings that won’t go away despite years of different treatments and diagnoses.

26 May 2004

Change of policy concerning generic product approvals

Following a recent judgment of the European Court of Justice in the 'Novartis' case (Case 106/01), the MHRA has decided to change its policy concerning the assessment of generic equivalents of line extension products.

26 May 2004

New website helps older Texans and disabled get information that may help them obtain their prescription drugs

The Texas Department on Aging has officially launching a "Texas Cares" website -- http://www.txcares.org -- to help older Texans and people with disabilities get information that may help them obtain their prescription drugs.

25 May 2004

$498 million to strengthen response to bioterror attacks, infectious diseases, and natural disasters

HHS Secretary Tommy G. Thompson today announced $498 million in awards to states, territories and four major metropolitan areas to strengthen the ability of hospitals and other health care facilities to respond to bioterror attacks, infectious diseases, and natural disasters that may cause mass casualties.

25 May 2004

Wyeth to seek rehearing of court ruling

Wyeth today said it would seek rehearing of a decision issued by the United States Court of Appeals for the Third Circuit reversing rulings by U.S. District Court Judge Harvey Bartle III of the Eastern District of Pennsylvania which excluded certain evidence in state court diet drug trials.

25 May 2004

Speakers will predict the future of where the field of cancer diagnosis and treatment is going in the next ten years

Nexxus, the West of Scotland Bioscience Network will hold the second event of the Horizons in Biomedicine Series today at 6.30pm at the Glasgow Science Centre.

25 May 2004

Collusion seen after release of flawed vaccine-autism report

America's leading scientific organization investigating the risks that mercury-containing medical products pose to our children-has posted the results of an investigative analysis of several authors relied upon for the flawed Institute of Medicine (IOM) report issued last week attempting to purport a lack of evidence to the mercury-vaccine-autism link.

25 May 2004

Study shows herpes is common in suburban populations, with Denver up to 20 percent

According to a recent study of 36 primary care physician (PCP) offices in relatively affluent suburban areas of six U.S. cities, one in four people (25.5 percent) tested positive for the virus that causes genital herpes, despite the fact that only four percent of all those tested reported a history of the condition.

24 May 2004

Cystic Fibrosis Foundation Therapeutics awards $21 million to Vertex

Vertex Pharmaceuticals Incorporated has announced that it has expanded its drug discovery and development collaboration with Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation.

24 May 2004

Innovative new cancer drug enters the first phase of clinical trials

An innovative drug with a new mechanism of action that may be effective against a range of cancers will enter the first phase of clinical trials, it was announced today (Monday) at Cancer Research UK's Senior Researchers Meeting.

24 May 2004

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates

Results from an ongoing surveillance study, PROTEKT US (Prospective Resistant Organism Tracking and Epidemiology of the Ketolide Telithromycin – United States) Year 2 (2001-2002), suggest that KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates, including those resistant to other antimicrobial agents.

24 May 2004

Pharmaceuticals News and Research

20 cancer survivors, loved ones and experts to join Lance Armstrong in raising cance awareness

Autodesk engineering solution addresses healthcare design challenges

There are still benefits from hormone therapy after menopause

Olympic organizers and world pharmaceutical representatives agree on working hours

Research tests the efficacy of a smallpox vaccine candidate known as LC16m8

Bipolar disorder, one of the illnesses that will be studied and treated at the new Mood Disorders Centre of Excellence

Change of policy concerning generic product approvals

New website helps older Texans and disabled get information that may help them obtain their prescription drugs

$498 million to strengthen response to bioterror attacks, infectious diseases, and natural disasters

Wyeth to seek rehearing of court ruling

Speakers will predict the future of where the field of cancer diagnosis and treatment is going in the next ten years

Collusion seen after release of flawed vaccine-autism report

Study shows herpes is common in suburban populations, with Denver up to 20 percent

Cystic Fibrosis Foundation Therapeutics awards $21 million to Vertex

Innovative new cancer drug enters the first phase of clinical trials

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates

Significant symptom relief reported in clinical trial patients with irritable bowel syndrome

An antibiotic, Tigecycline produces 74 percent cure rate in cSSSI patients

New treatment for dry eye syndrome (keratoconjunctivitis sicca)

Novogen granted Canadian patent for health supplements for the treatment of menopause symptoms

Drug Discovery - Second Edition eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News